Cymabay Therapeutics Inc CBAY:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 11/25/22 EST
3.30UNCH (UNCH)
Volume
2
Close
3.30quote price arrow down-0.01 (-0.30%)
Volume
63,456
52 week range
1.67 - 4.30
Loading...
  • Open3.29
  • Day High3.37
  • Day Low3.27
  • Prev Close3.31
  • 52 Week High4.30
  • 52 Week High Date08/08/22
  • 52 Week Low1.67
  • 52 Week Low Date05/11/22

Key Stats

  • Market Cap279.437M
  • Shares Out84.68M
  • 10 Day Average Volume0.33M
  • Dividend-
  • Dividend Yield-
  • Beta0.55
  • YTD % Change-2.37

KEY STATS

  • Open3.29
  • Day High3.37
  • Day Low3.27
  • Prev Close3.31
  • 52 Week High4.30
  • 52 Week High Date08/08/22
  • 52 Week Low1.67
  • 52 Week Low Date05/11/22
  • Market Cap279.437M
  • Shares Out84.68M
  • 10 Day Average Volume0.33M
  • Dividend-
  • Dividend Yield-
  • Beta0.55
  • YTD % Change-2.37

RATIOS/PROFITABILITY

  • EPS (TTM)-1.25
  • P/E (TTM)-2.65
  • Fwd P/E (NTM)-2.70
  • EBITDA (TTM)-93.445M
  • ROE (TTM)-143.87%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,116.61%
  • Debt To Equity (MRQ)143.16%

EVENTS

  • Earnings Date03/15/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cymabay Therapeutics Inc

 

Profile

MORE
CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and providing access to therapies for patients with liver and other chronic diseases. The Company's lead product candidate, seladelpar, is a potent and selective agonist of peroxisome proliferator activated receptor delta (PPARd), a nuclear receptor that regulates genes directly or indirectly involved in the synthesis of bile acids/sterols, metabolism of lipids and...
Robert Wills Ph.D.
Independent Chairman of the Board
Sujal Shah
President, Chief Executive Officer, Director
Daniel Menold
Vice President - Finance
Address
SUITE 130, 7999 GATEWAY BLVD
Newark, CA
94560
United States

Top Peers

SYMBOLLASTCHG%CHG
IVVD
Invivyd Inc
2.14-0.12-5.31%
TYRA
Tyra Biosciences Inc
6.75-0.29-4.12%
ANNX
Annexon Inc
5.85+0.05+0.86%
GRCL
Gracell Biotechnologies Inc
3.37-0.11-3.16%
ALDX
Aldeyra Therapeutics Inc
5.46+0.08+1.49%